The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 4th 2025
New trials reveal xanomeline and trospium effectively alleviate schizophrenia symptoms, offering a novel treatment option with minimal adverse effects.
Biosimilar Ranibizumab Could be More Cost-Effective Than Aflibercept for nAMD
July 15th 2024Switching from aflibercept (Eylea; Regeneron Pharmaceuticals) to biosimilar ranibizumab (Lucentis; Genentech) for neovascular age-related macular degeneration could be more cost effective for patients.
Read More
Pharmacy Focus: What to Know About Medication and Summer Travel
July 12th 2024Jeffrey Goad discusses key considerations for travelers regarding medications, maintaining medication schedules across time zones, ensuring proper vaccinations, and the importance of consulting health care professionals before international trips.
Listen
FTC Intends to Sue Biggest Pharmacy Benefit Managers for Unfair Negotiating Tactics
July 11th 2024In a follow-up to the interim FTC report documenting the business practices of PBMs and the power they hold in the pharmaceutical industry, the Commission now seeks to sue the 3 largest PBMs in the country for driving up the price of insulin and other essential drugs.
Read More
Understand the Effects of Topical Nasal Decongestants on Blood Pressure
Because decongestants act by constricting blood vessels, their use can be problematic in individuals who have hypertension.
Read More